| Targeting huntingtin expression in patients with Huntington’s disease SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ... New England Journal of Medicine 380 (24), 2307-2316, 2019 | 679 | 2019 |
| CAG repeat not polyglutamine length determines timing of Huntington’s disease onset JM Lee, K Correia, J Loupe, KH Kim, D Barker, EP Hong, MJ Chao, ... Cell 178 (4), 887-900. e14, 2019 | 307 | 2019 |
| Double-stranded DNA translocation: structure and mechanism of hexameric FtsK TH Massey, CP Mercogliano, J Yates, DJ Sherratt, J Löwe Molecular cell 23 (4), 457-469, 2006 | 281 | 2006 |
| Topical NSAIDs for acute pain in adults T Massey, S Derry, RA Moore, HJ McQuay Cochrane Database of Systematic Reviews, 2010 | 269 | 2010 |
| The central role of DNA damage and repair in CAG repeat diseases TH Massey, L Jones Disease models & mechanisms 11 (1), dmm031930, 2018 | 111 | 2018 |
| Recombination and chromosome segregation DJ Sherratt, B Søballe, FX Barre, S Filipe, I Lau, T Massey, J Yates Philosophical Transactions of the Royal Society of London. Series B …, 2004 | 98 | 2004 |
| Timing and impact of psychiatric, cognitive, and motor abnormalities in Huntington disease B McAllister, JF Gusella, GB Landwehrmeyer, JM Lee, ME MacDonald, ... Neurology 96 (19), e2395-e2406, 2021 | 81 | 2021 |
| Asymmetric activation of Xer site‐specific recombination by FtsK TH Massey, L Aussel, FX Barre, DJ Sherratt EMBO reports 5 (4), 399-404, 2004 | 74 | 2004 |
| Genetic modifiers of Mendelian disease: Huntington’s disease and the trinucleotide repeat disorders PA Holmans, TH Massey, L Jones Human molecular genetics 26 (R2), R83-R90, 2017 | 63 | 2017 |
| Dentatorubral-pallidoluysian atrophy: an update LS Carroll, TH Massey, M Wardle, KJ Peall Tremor and Other Hyperkinetic Movements 8, 2018 | 62 | 2018 |
| Clinical presentation and features of juvenile-onset Huntington’s disease: a systematic review T Cronin, A Rosser, T Massey Journal of Huntington's disease 8 (2), 171-179, 2019 | 58 | 2019 |
| Sgf1p, a new component of the Sec34p/Sec35p complex DW Kim, T Massey, M Sacher, M Pypaert, S Ferro‐Novick Traffic 2 (11), 820-830, 2001 | 49 | 2001 |
| Genetic modifiers of Huntington disease differentially influence motor and cognitive domains JM Lee, Y Huang, M Orth, T Gillis, J Siciliano, E Hong, JS Mysore, ... The American Journal of Human Genetics 109 (5), 885-899, 2022 | 48 | 2022 |
| Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset B McAllister, J Donaldson, CS Binda, S Powell, U Chughtai, G Edwards, ... Nature neuroscience 25 (4), 446-457, 2022 | 43 | 2022 |
| Nitrous oxide misuse and vitamin B12 deficiency TH Massey, TT Pickersgill, KJ Peall Case Reports 2016, bcr2016215728, 2016 | 43 | 2016 |
| Genetic risk underlying psychiatric and cognitive symptoms in Huntington’s disease N Ellis, A Tee, B McAllister, T Massey, D McLauchlan, T Stone, K Correia, ... Biological Psychiatry 87 (9), 857-865, 2020 | 35 | 2020 |
| Clinical characterization of dystonia in adult patients with Huntington's disease NA Van de Zande, TH Massey, D McLauchlan, A Pryce Roberts, R Zutt, ... European journal of neurology 24 (9), 1140-1147, 2017 | 27 | 2017 |
| J Peall K TH Massey, TT Pickersgill Nitrous oxide misuse and vitamin B12 deficiency. BMJ Case Rep 2016, 2016 | 18 | 2016 |
| Changes in white matter microstructure and MRI-derived cerebral blood flow after 1-week of exercise training JJ Steventon, HL Chandler, C Foster, H Dingsdale, M Germuska, ... Scientific reports 11 (1), 22061, 2021 | 13 | 2021 |
| Repurposing drugs to treat neurological diseases TH Massey, NP Robertson Journal of neurology 265, 446-448, 2018 | 13 | 2018 |
